SOX2 and neoplasm: Analysis of the tumor compartment in PCPs clearly showed that activation of the MAPK signaling pathway, secondary to BRAFV600E mutation, only occurred in a subset of cells, namely those that exhibit both a marker of precursor dedifferentiation (SOX2) and a proliferation marker (Ki-67).